Tokai AI Stock Analysis
Want to see JP:9729 full AI Analyst Report?
Tokai (9729) AI Stock Analysis
Tokai
(TSE/TYO:9729)
Tokai earns a solid, moderately above-average score. Financial performance is the dominant driver: an exceptionally conservative balance sheet with minimal leverage and consistent 4–6% revenue growth provides downside protection, though thin net margins (3.2%), declining return on equity, and volatile free cash flow cap the upside and highlight questions around capital efficiency. Supporting the score, the stock trades above all major moving averages with positive MACD momentum and neutral RSI, indicating a healthy uptrend with room to run. Valuation adds further support via a modest 13.8x P/E, a 2.66% dividend yield, and low beta of 0.61, making this a defensive, reasonably priced holding. The key swing factor ahead is whether FY2026 projections for improved earnings and free cash flow are realized.
Tokai (9729) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 89.15B
- Dividend Yield
- 2.69%
- Average Volume (3M)
- 44.75K
- Price to Earnings (P/E)
- 13.7
- Beta (1Y)
- 0.61
- Revenue Growth
- 4.43%
- EPS Growth
- 44.73%
- Country
- Japan
- Employees
- 4,694
- Sector
- Consumer Cyclical
- Sector Strength
- 61
- Industry
- Medical - Care Facilities
Tokai Business Overview & Revenue Model
Company Description
Established in 1955 and headquartered in Gifu, Japan, TOKAI Corp. offers a comprehensive suite of services throughout Japan, centered around enhancing the quality of life. Within the healthcare sector, the company is a key provider, offering rental s...
How the Company Makes Money
null
Tokai Financial Statement Overview
Summary
A blend of the Income Statement (55), Balance Sheet (78), and Cash Flow (62) scores. The standout strength is a near-fortress balance sheet, with debt-to-equity consistently below 0.05 and equity compounding from ¥73.4bn to ¥85.2bn. Revenue has grown steadily from ¥118.0bn (FY2021) to ¥149.5bn (FY2025), with ¥159.7bn guided for FY2026. Offsetting this, net margins are thin and have compressed from ~4.7% (FY2023) to 3.2% (FY2025), ROE has slipped from ~7.5% to 5.6%, and free cash flow has been volatile, including a negative ¥372m year in FY2024. FY2026 projections point to a rebound in earnings (¥6.1bn) and free cash flow (¥8.2bn), which would mark a positive inflection if delivered.
Income Statement
55NeutralBalance Sheet
78PositiveCash Flow
62Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 161.06B | 159.66B | 149.54B | 138.22B | 130.18B | 123.48B |
| Gross Profit | 39.54B | 38.78B | 35.44B | 33.64B | 31.92B | 30.98B |
| EBITDA | 14.58B | 14.59B | 12.47B | 13.13B | 13.26B | 12.63B |
| Net Income | 6.16B | 6.07B | 4.73B | 5.81B | 6.11B | 5.81B |
Balance Sheet | ||||||
| Total Assets | 116.60B | 114.69B | 113.95B | 114.93B | 110.78B | 105.90B |
| Cash, Cash Equivalents and Short-Term Investments | 26.83B | 26.48B | 26.89B | 31.69B | 37.01B | 36.16B |
| Total Debt | 4.70B | 3.22B | 2.65B | 2.35B | 2.87B | 3.40B |
| Total Liabilities | 31.28B | 30.26B | 28.10B | 28.14B | 28.56B | 28.38B |
| Stockholders Equity | 84.53B | 83.72B | 85.19B | 86.18B | 81.66B | 77.00B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 8.16B | 5.99B | -372.00M | 2.94B | 6.49B |
| Operating Cash Flow | 0 | 11.44B | 10.10B | 8.04B | 8.59B | 10.13B |
| Investing Cash Flow | 0 | -4.23B | -11.41B | -10.21B | -6.24B | -6.74B |
| Financing Cash Flow | 0 | -7.83B | -5.20B | -3.20B | -2.43B | -2.90B |
Tokai Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9729, the sentiment is Positive. The current price of 2756.00 is below the 20-day moving average (MA) of 2789.45, above the 50-day MA of 2633.15, and above the 200-day MA of 2487.06, indicating a neutral trend. The MACD of 29.63 indicates Positive momentum. The RSI at 52.50 is Neutral, neither overbought nor oversold. The STOCH value of 63.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9729.
Tokai Peers Comparison
Overall Rating
JP:969975Outperform
JP:972968Neutral
JP:843966Neutral
JP:583461Neutral
JP:842453Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 75Outperform | JPY 126.00B | 9.79 | ― | 3.03% | 0.17% | 3.63% | |
| 68Neutral | JPY 89.15B | 13.65 | 7.54% | 2.69% | 4.43% | 44.73% | |
| 66Neutral | JPY 1.30T | 14.86 | ― | 3.63% | 10.62% | -35.62% | |
| Sector * | 61Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
| 61Neutral | JPY 38.44B | 5.55 | ― | 4.98% | 47.13% | 16.70% | |
| 53Neutral | JPY 373.55B | 9.92 | ― | 4.00% | 21.37% | 37.39% |
* Consumer Cyclical Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:9729 | Tokai Corp | 2756.00 | 409.44 | 17.45% | |
| JP:5834 | SBI Leasing Services Co.,Ltd. | 2411.00 | -35.93 | -1.47% | |
| JP:8424 | Fuyo General Lease Co., Ltd. | 4124.00 | 175.93 | 4.46% | |
| JP:8439 | Tokyo Century Corporation | 2641.50 | 773.28 | 41.39% | |
| JP:9699 | NISHIO HOLDINGS CO. LTD. | 4490.00 | 292.63 | 6.97% | |
| JP:372A | Rent Corporation | 5870.00 | 555.85 | 10.46% |
Tokai Corporate Events
TOKAI Reports Record-High FY3/27 Second-Quarter Sales and Profit
TOKAI Corp. reported that net sales and profit at all levels reached record highs in the second quarter of FY3/27. The company revised its full-year business forecast upward, changing initial expectations for year-on-year declines in operating and or...
Tokai Reports Higher First-Half Sales and Profit
Tokai Corp. reported consolidated net sales of ¥82,111 million for the six months ended Sept. 30, 2026, up 3.9% year over year. Operating profit rose 11.5% to ¥4,920 million, ordinary profit increased 10.6% to ¥5,170 million, and profit attributable...
Tokai Lifts Earnings and Dividend Forecasts on Strong Healthcare and Elderly Care Gains
Tokai Corp. is a Japan-based service company listed on the Tokyo Stock Exchange Prime Market, operating primarily in the dispensing pharmacy and elderly care businesses. The group focuses on prescription-related services, including drug and technical...
Tokai Corp. Announces Passing and Resignation of Outside Director
Tokai Corp. has announced the passing of outside director and independent officer Kenji Kawashima on September 30, 2026, which resulted in his resignation from the board on the same date. The company expressed gratitude for Kawashima’s contributions...
Tokai to Acquire Regional Welfare Equipment Units via Simplified Company Splits
Tokai Corp. has approved simplified absorption-type company splits to take over the welfare equipment rental, sales and home modification businesses of K-WORKER Co., Ltd. in Tokyo and Araki Mari-n Co., Ltd. in Kumamoto. The transfer, effective Novemb...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
